Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6151-5. doi: 10.1016/j.bmcl.2008.10.013. Epub 2008 Oct 7.

Abstract

The design synthesis and SAR of a series of chiral ring-constrained norepinephrine reuptake inhibitors with improved physicochemical properties is described. Typical compounds are potent (IC(50)s<10 nM), selective against the other monoamine transporters, weak CYP2D6 inhibitors (IC(50)s>1 microM) and stable to oxidation by human liver microsomes. In addition, the compounds exhibit a favorable polarity profile.

MeSH terms

  • Atomoxetine Hydrochloride
  • Combinatorial Chemistry Techniques
  • Cytochrome P-450 CYP2D6 Inhibitors*
  • Drug Design
  • Humans
  • Indans / chemical synthesis*
  • Indans / chemistry
  • Indans / pharmacology*
  • Inhibitory Concentration 50
  • Microsomes, Liver / metabolism
  • Molecular Structure
  • Neurotransmitter Uptake Inhibitors / chemical synthesis*
  • Neurotransmitter Uptake Inhibitors / chemistry
  • Neurotransmitter Uptake Inhibitors / pharmacology*
  • Norepinephrine / antagonists & inhibitors*
  • Propylamines / pharmacology
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Cytochrome P-450 CYP2D6 Inhibitors
  • Indans
  • Neurotransmitter Uptake Inhibitors
  • Propylamines
  • Atomoxetine Hydrochloride
  • Norepinephrine